G42 Healthcare opens the first Proteomics-certified site in the EMEA region.

Facebook
Twitter
LinkedIn
G42 Healthcare launches first certified Proteomics site in EMEA region
G42 Healthcare launches first certified Proteomics site in EMEA region

G42 Healthcareโ€™s Somalogic Proteomics Laboratory, part of the Omics Centre of Excellence, is now officially certified with the SomaScan Discovery Assay, making it the first certified Proteomics site in EMEA region.

This achievement comes on the heels of the recent launch of M42, a first-of-its-kind, tech-enabled, integrated healthcare company created through the coming together ofย G42 Healthcareย andย Mubadala Health that combines G42 Healthcareโ€™s unique medical and data-centric technologies with Mubadala Healthโ€™s world-class patient services and state-of-the-art facilities to provide the highest level of personalized, precise, and preventative care.

G42 Healthcare logo

The coveted milestone builds on the recent partnership between G42 Healthcare โ€“ a leading Abu Dhabi-based AI health-tech company, and SomaLogic, a leader in data-driven proteomics, which is the study of the interactions, function, composition, and structures of proteins and their cellular activities.

G42 Healthcare earned the certification upon passing the SomaSignal Assay performance requirements, spearheaded by SomaLogic. The recently-earned certification equips G42 Healthcare to support and drive clinical decisions as well as future development of tests using genomic, proteomic and clinical characteristics. Both teams are committed to develop future protein signatures for the people of the UAE, including validating tests that can predict cardiovascular risk 4 years ahead of time, which will have huge impact on personalized treatments and reduce the long-term cost to healthcare providers.

Pharma-2

The SomaScan platform was designed as a universal platform that can be applied across research and discovery, translational research, biopharmaceutical development, and clinical applications.

G42 Healthcare and SomaLogic also plan to collaborate on business development, strategy, and applications for the life sciences and healthcare markets, including championing SomaSignal tests in UAE, Saudi Arabia, GCC and selected broader territories.

Source

Also read:

Bravo Pharma collaborates with G42 healthcare

G42 partners with Microsoft to accelerate UAEโ€™s digital transformation

Share.

RELATED POSTS

Public-Investment-Fund-and-Talaat-Moustafa-Group-sign-MoU.-Image-Courtesy: Public-Investment-Fund
PIF, TMG sign MoU to Explore Opportunities in Realty Sector
Fawaz Alโ€‘Nakib, Loyalty and Partnership Manager at Weyay Bank. Image courtesy: Weyay Bank
Weyay Bank partners with Nafas Center to promote well being
ORA Developers has launched Y Views at Bayn, an ultra-luxury enclave inside the 4.8 million square metre Bayn masterplan in Ghantoot, signalling a new push to develop the strip between Dubai and Abu Dhabi as a premium residential corridor. Image courtesy: ORA Developers
ORA Developers Launches Y Views at Bayn

LATEST POSTS

chasing unpaid medical bills has become a global business story. Image Courtesy-Magnific
(Right) Matteo Bavaresco, newly appointed Group CEO, Ducab. Image Courtesy-Ducab
Narrative Shapers, a Saudi-based advisory firm, has launched a service for Saudi-based developers to help them accelerate their efforts to build both their brand and sales overseas. Image courtesy: Narrative Shapers
Tesla and Esyasoft agreement signing ceremony. Image Courtesy-Esyasoft